Clarke, P. D.; Leslie, A.; Jack, F.; Steel, R. J. C.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA67
Academic Journal
The article presents a study to elicit whether anticoagulant medication can affect the false positive rate of fecal occult blood (FOB) testing. The data for the study were obtained from the colorectal cancer pilot screening programme conducted on Tayside (Scotland) in 50-69 year olds. 846 patients who had tested FOB positive were studied prospectively. The result of each individual's colonoscopy report was accessed and linked to the medication they were taking. This information was then correlated to analyze the effect of anticoagulant medication on the false positive rate.


Related Articles

  • New advice on faecal occult blood testing.  // Pulse;4/12/2004, Vol. 64 Issue 15, p15 

    Reports on the results of a study recommending that patients taking non-essential anticoagulants should stop their medication before colorectal cancer screening. Fecal occult blood testing; Rates of false positive results in people taking anticoagulant medication; Tayside screening program of...

  • Colorectal Cancer in Russian-Speaking Jewish Emigrés: Community-Based Screening. Vadlamani, Lalit; Maher, James F.; Shaete, Mona; Smirnoff, Alex; Cameron, Daniel G.; Winkelmann, John C.; Goldberg, Stephen J. // American Journal of Gastroenterology;Sep2001, Vol. 96 Issue 9, p2755 

    OBJECTIVES: Colorectal cancer (CRC) screening by fecal occult blood testing and flexible sigmoidoscopy is recommended by many authorities for those older than age 50. Ashkenazi Jews have been shown to have a higher level of CRC and polyps than the general population. A subset of Ashkenazi Jews,...

  • Bowel tests to go national. Dragon, Natalie // GP: General Practitioner;7/14/2003, p3 

    A national bowel screening programme, based on faecal occult blood (FOB) testing, is expected to be rolled out within months, according to researchers involved in recently completed pilots. Results from two two-year-long FOB pilots, carried out in England and Scotland, show the approach is both...

  • Effect of faecal occult blood testing on colorectal cancer mortality in the surveillance of subjects at moderate risk of colorectal neoplasia: a case-control study. Lamah, M.; Norris, J.; Caffarey, S. M.; Broughton, M.; Marks, C. G. // International Journal of Colorectal Disease;Sep2001, Vol. 16 Issue 5, p313 

    Colonoscopy is the established method of surveillance of subjects at high risk of developing colorectal neoplasia. Its role in the surveillance of a population at moderate risk is less clear, however, as the procedure is expensive, time consuming and occasionally hazardous. The aim of this study...

  • Fecal Occult Blood Testing in a Noncompliant Inner City Minority Population: Increased Compliance and Adherence to Screening Procedures Without Loss of Test Sensitivity Using Stool Obtained at the Time of In-Office Rectal Examination. Parikh, Ameet; Ramamoorthy, Ravishankar; Kim, Kyung H.; Holland, Bart K.; Houghton, JeanMarie // American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1908 

    OBJECTIVES: Fecal occult blood screening is cost-effective, is easily administered to large groups of patients, and reduces mortality associated with colorectal cancer. Within our predominant African American and Latino inner city clinic populations, compliance with common screening procedures...

  • Fecal Occult Blood Test Screening in the United Kingdom. Steele, Robert J. C. // American Journal of Gastroenterology;Feb2006, Vol. 101 Issue 2, p216 

    The article focuses on the status of the fecal occult blood testing (FOBT) as a strategy for colorectal cancer screening in Great Britain. The whole screening program in the country comprises biyearly FOBT screening on a centralized basis. FOBT screening in the country is cheap and safe. It is...

  • Colorectal Cancer Screening with Fecal Occult Blood Testing (FOBT): An International Perspective. Achkar, Edgar; Moayyedi, Paul // American Journal of Gastroenterology;Feb2006, Vol. 101 Issue 2, p212 

    The article focuses on the status of the fecal occult blood testing (FOBT) as a reasonable strategy for colorectal cancer screening in different countries. In the U.S., FOBT reduces mortality related to colorectal cancer by 33 percent. Meanwhile, in Great Britain, it reduces colorectal cancer...

  • The Case for Direct Colonoscopy Screening for Colorectal Cancer. Bond, John H. // American Journal of Gastroenterology;Feb2006, Vol. 101 Issue 2, p263 

    Recent large series of direct colonoscopy screening for colorectal cancer increase our understanding of the advantages of this approach, and have indirectly confirmed efficacy. When performed by well-trained, experienced endoscopists, colonoscopy screening is successful and safe. The prevalence...

  • Option appraisal of population-based colorectal cancer screening programmes in England. Tappenden, Paul; Chilcott, James; Eggington, Simon; Patnick, Julietta; Sakai, Hannah; Karnon, Jonathon // Gut;May2007, Vol. 56 Issue 5, p677 

    Objectives: To estimate the effectiveness, cost-effectiveness and resource impact of faecal occult blood testing (FOBT) and flexible sigmoidoscopy (FSIG) screening options for colorectal cancer to inform the Department of Health's policy on bowel cancer screening in England. Methods: We...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics